What's new

Human medicines European public assessment report (EPAR): Duavive, oestrogens conjugated,bazedoxifene, Date of authorisation: 16/12/2014, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Duavive, oestrogens conjugated,bazedoxifene, Date of authorisation: 16/12/2014, Revision: 17, Status: Authorised

May 20, 2025 - 12:15
 0
Human medicines European public assessment report (EPAR): Duavive, oestrogens conjugated,bazedoxifene, Date of authorisation: 16/12/2014, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Duavive, oestrogens conjugated,bazedoxifene, Date of authorisation: 16/12/2014, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Conbriza, bazedoxifene...

Next Article

What Germany’s ‘sea-change’ shift on nuclear power means for the industry

Related Posts

EMA workshop on primary efficacy endpoints for antivirals and monoclonal antibodies intended for the treatment of COVID-19 and influenza, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 June 2025, 13:00 (CEST) to 6 June 2025, 17:00 (CEST)

EMA workshop on primary efficacy endpoints for antivira...

May 13, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0364/2022

Opinion/decision on a Paediatric investigation plan (PI...

May 20, 2025  0

European shortages monitoring platform (ESMP): updates and question and answer (Q&A) clinic for marketing authorisation holders (MAHs), Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 June 2025, 10:30 (CEST) to 24 June 2025, 12:00 (CEST)

European shortages monitoring platform (ESMP): updates ...

May 14, 2025  0